Mary L. (Nora) Disis, M.D.
Director, UW Medicine Cancer Vaccine Institute
Helen B. Slonaker Endowed Professorship for Cancer Research
Dr. Disis was educated at the University of Nebraska Medical School, the University of Illinois College of Medicine and UW Medicine-Fred Hutchinson Cancer Research Center. She was one of the pioneering investigators who discovered that HER-2/neu is a tumor antigen, and she holds several patents in the field of targeted cancer therapy and cancer diagnostics. In addition, she serves as the inaugural editor-in-chief of JAMA Oncology. Read more about Dr. Disis.
The Cancer Vaccine Institute is a group of multidisciplinary investigators who work to support a comprehensive research effort for evaluating the role of the immune system in modulating cancer and develop novel therapies that will impact the lives of people with the disease. The overall goals of the program are to define cancer-immune interactions that will result in the development diagnostic, preventative, and treatment strategies to combat cancers.